Nanogen, Inc. News, Nanogen, Inc. Quote, NGEN Quote

Nanogen, Inc. (NQ:NGEN) Delayed: 1.59 -0.03 (1.85%)

Prev. Close

$1.62

Today 6M 1Y 5Y

Open

$1.63

52 Wk High

$0.01

52 Wk Low

$0.00

Day High

$1.66

Day Low

$1.58

P/E

N/A

EPS

$0.00

Volume

388,368

Friends, Peers and Foes (?): NGENF (more...)

ALERTS | RSS

Oct 16, 2026 04:32 PM Form 6-K/A NERVGEN PHARMA CORP. For: Aug 13
Oct 16, 2026 04:31 PM Form 40-F/A NERVGEN PHARMA CORP. For: Dec 31
Oct 12, 2026 07:15 AM NervGen doses first participant in Phase 3 spinal cord injury trial
Oct 12, 2026 07:15 AM NervGen Announces First Participant Dosed in RESTORE, a Phase 3 Registrational Study Evaluating NVG-291 in Chronic Spinal Cord Injury
Sep 25, 2026 04:31 PM Form 6-K NERVGEN PHARMA CORP. For: Sep 25
Sep 25, 2026 04:30 PM NervGen to Restate Previously Filed Financial Statements Recognizing Non-Cash Accounting Adjustments
Sep 24, 2026 08:28 AM Form 6-K NERVGEN PHARMA CORP. For: Sep 24
Sep 9, 2026 07:30 AM NervGen to Host Inaugural R&D Day on September 30, 2026
Aug 13, 2026 07:31 AM Form 6-K NERVGEN PHARMA CORP. For: Aug 13
Aug 13, 2026 07:30 AM NervGen Reports Second Quarter 2026 Financial Results and Provides Business Updates

Entities mentioned with NGEN

View All Entities